Discovery of a Novel Covalent EZH2 Inhibitor Based on Tazemetostat Scaffold for the Treatment of Ovarian Cancer

Qiangsheng Zhang(Bozhou People's Hospital), Luoting Yu(Sichuan University), Guoquan Wan(Sichuan University), Ningyu Wang(Southwest Jiaotong University), Hongling Yang(Sichuan University), Jiaying Cao(Sichuan University), Hongtao Xiao(University of Electronic Science and Technology of China), Zhihao Liu(Sichuan University), Xinyi Chen(Sichuan University), Yongxia Zhu(University of Electronic Science and Technology of China), Qiang Feng(Hong Kong University of Science and Technology), Shuyan Zhou(Georgetown University), Wan Seok Yang(St. John's University)
Journal of Medicinal Chemistry
January 24, 2023
Cited by 24


Related Papers